Song Y, Shryock JC, Belardinelli L. A slowly inactivating sodium current contributes to spontaneous diastolic depolarization of atrial myocytes. Am J Physiol Heart Circ Physiol 297: H1254 -H1262, 2009. First published August 21, 2009 doi:10.1152/ajpheart.00444.2009.-Diastolic depolarization (DD) of atrial myocytes can lead to spontaneous action potentials (APs) and, potentially, atrial tachyarrhythmias. This study examined the hypotheses that 1) a slowly inactivating component of the Na ϩ current (referred to as late INa) may contribute to DD and initiate AP firing and that 2) blocking late I Na will reduce spontaneous and induced firing of APs by atrial myocytes. Guinea pig atrial myocytes without or with DD and spontaneous AP firing were studied using the whole cell patch-clamp technique. In experiments using cells with a stable resting membrane potential (no spontaneous DD or firing), hydrogen peroxide (H 2O2, 50 mol/l) caused DD and AP firing. The H 2O2-induced activity was suppressed by the late INa inhibitors tetrodotoxin (TTX, 1 mol/l) and ranolazine (5 mol/l). In cells with DD but no spontaneous APs, the late I Na enhancer anemone toxin II (ATX-II, 10 nmol/l) accelerated DD and induced APs. In cells with DD and spontaneous AP firing, TTX and ranolazine (both, 1 mol/l) significantly reduced the slope of DD by 81 Ϯ 12% and 75 Ϯ 11% and the frequency of spontaneous firing by 70 Ϯ 15% and 74 Ϯ 9%, respectively. Ramp voltage-clamp simulating DD elicited a slow inward current. TTX at 1, 3, and 10 mol/l inhibited this current by 41 Ϯ 4%, 73 Ϯ 2%, and 91 Ϯ 1%, respectively, suggesting that a slowly inactivating I Na underlies the DD. ATX-II and H2O2 increased the amplitude of this current, and the effects of ATX-II and H 2O2 were attenuated by ranolazine or TTX. In conclusion, late INa can contribute to the DD of atrial myocytes and the inhibition of this current suppresses atrial DD and spontaneous APs. late sodium current; action potential; spontaneous activity DIASTOLIC DEPOLARIZATION (DD) that may lead to rapid action potential (AP) firing is often observed in cardiac atrial preparations, including atrial fibers excised from human hearts (7, 28, 42) , and in multicellular (13, 31, 32, 49) or single cell (14, 50) preparations from various animal species. Although the increased automaticity caused by DD has been recognized as one of the major mechanisms to initiate atrial fibrillation (29, 41) , the ionic basis underlying DD of atrial myocytes is not fully understood.
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Multiple membrane currents may contribute to DD. The results of experiments on cat atrial myocytes showed that both T-type Ca 2ϩ current [I Ca(T) ] and Na ϩ -Ca 2ϩ exchange current (I Na-Ca ) are involved in DD and abnormal automaticity (14) , whereas the results of a study of human atrial fibers suggest a role for the pacemaker current I f in DD (7) . On the other hand, a study of human atrial fibers (28) found that tetrodotoxin (TTX) markedly decreased the slope of DD, suggesting that a TTX-inhibited, slowly inactivating Na ϩ current (I Na ) may play a role in the development of atrial DD. However, this potential mechanism for enhanced atrial automaticity has received little attention.
I Na is responsible for initiating the upstroke of the atrial AP, and following activation, the current rapidly inactivates. However, after the initial rapid inactivation, a small fraction of noninactivating I Na persists even during the late phase of the AP (8, 22) . This persistent component of I Na , caused by bursts and late-scattered openings of single channels (26) , is referred to as late, persistent, or sustained I Na . Late I Na can be activated and observed in cardiac myocytes of various species following the application of either square or ramp voltage-clamp pulses within a broad voltage range (2, 24, 33, 35) . The amplitude of late I Na decreases as the slope of the ramp pulse is reduced (2), indicating that late I Na undergoes a time-dependent, slow inactivation. Thus late I Na is distinct from the Na ϩ window current, which is a steady-state, time-independent current that is present throughout the voltage range where the activation and inactivation relationships of I Na overlap (34) . The potential for a role of late I Na in the genesis of DD lies in the fact that this inward current is present at voltages as negative as Ϫ70 mV in ventricular myocytes (33, 35) and Ϫ80 mV in Purkinje fibers (5); these membrane potentials are well within the reported voltage range for DD in atrial tissues (7, 28, 42) . Because of its slow inactivation, late I Na may be activated during atrial DD, as suggested by the results of a previous study by Mary-Rabine et al. (28) .
Although late I Na is normally small in magnitude, it may be enhanced in a variety of conditions that are associated with increased automaticity, e.g., by inherited or acquired Na ϩ channelopathies such as that caused by reactive oxygen species, including hydrogen peroxide (H 2 O 2 ) (23, 39, 48) . Therefore, late I Na could play a significant role in the development of DD and AP firing under pathological conditions. Pharmacologically, late I Na can be specifically enhanced by anemone toxin II (ATX-II) (15) , and it can be selectively inhibited by low concentrations of TTX (24) or by the antianginal agent ranolazine (1, 40, 43) .
The density of I Na in atrial myocytes is reported to be high (4, 19) . We therefore tested the hypothesis that a slowly inactivating I Na contributes to atrial DD and spontaneous AP firing, using guinea pig isolated single atrial myocytes in which DD and AP firing were induced by the exposure of cells to low concentrations of ATX-II or H 2 O 2 or in which DD without or with spontaneous AP firing was "intrinsically" present. If the hypothesis that late I Na contributes to DD is correct, then enhancers of late I Na such as ATX-II and H 2 O 2 should increase atrial cell late I Na , DD, and spontaneous AP firing and inhib-itors of the current, such as TTX and ranolazine, should have the opposite effect.
MATERIALS AND METHODS
Isolation of atrial myocytes. Animal use in this investigation conformed to the Guide for the Care and Use of Laboratory Animals published by National Institutes of Health (NIH Publication No. 85-23, Revised 1996) and was approved by the Institutional Animal Care and Use Committee. Atrial myocytes were isolated from the hearts of adult Hartley guinea pigs of either sex using a standard enzymatic method, as previously described (38) .
Measurements of transmembrane potential and current. Cells were placed into a recording chamber and perfused with Tyrode solution containing (in mmol/l) 135 NaCl, 4.6 KCl, 1.8 CaCl 2, 1.1 MgSO4, 10 glucose, and 10 HEPES (pH 7.4). Drugs were applied through the bath solution. Transmembrane voltages and currents were recorded using the whole cell configuration of the patch-clamp technique, as previously described (38) . All experiments were performed at 36°C.
For the recording of membrane potentials, glass capillary micropipettes were filled with a solution containing (in mmol/l) 120 K ϩ -aspartate, 20 KCl, 1 MgSO 4, 4 Na2ATP, 0.1 Na3GTP, and 10 HEPES (pH 7.2) and used as microelectrodes. To induce APs, 5-ms depolarizing pulses were applied to a myocyte at a frequency of 0.16 Hz. The slope (in mV/s) of DD and the maximum rise slope (MRS, in V/s) of AP were measured with pClamp software. To minimize statistical errors due to beat-to-beat variation of DD, the slopes of DD for each of the 5-10 different APs were calculated during each treatment period (control or drug) and the mean slope was determined and reported herein.
To study the inactivation-resistant component(s) of I Na, a ramp voltage-clamp pulse from Ϫ80 to Ϫ40 mV at a slope of 40 -80 mV/s, or a 300-ms square voltage-clamp pulse from Ϫ90 to Ϫ60 or Ϫ50 mV, was applied to a myocyte at a frequency of 0.16 Hz. The cell capacitive transients were reduced using the amplifier, and the values read from the capacitance meter were used to normalize the amplitude of current. The amplitude of late I Na generated by a ramp pulse was measured as the maximal inward deflection of current. The magnitude of late I Na activated by a square-wave pulse was determined as the average amplitude of inward current during the last 50 ms of the pulse, using pClamp software. To minimize the contamination of I Na with K ϩ , Ca 2ϩ , inward Na ϩ -Ca 2ϩ exchanger, and the pacemaker (If) currents, K ϩ in both the pipette and bath solutions was replaced with equimolar Cs ϩ , and EGTA (1 mmol/l) and nitrendipine (10 mol/l) were added to the pipette and bath solutions, respectively.
Statistical analysis. Data are expressed as means Ϯ SE. Values of n indicate the number of cells studied. Each cell serves as its own control in the measurement. The paired t-test and one-or two-way repeated-measures ANOVA followed by Holm-Sidak method were applied as appropriate to determine the significance of differences between or among treatment group values. A difference with a P value Ͻ 0.05 was considered statistically significant.
RESULTS
In this study, it was observed that isolated atrial myocytes could be separated into three groups based on differences in electrical activity. Myocytes from all three groups were studied. The majority of myocytes displayed a stable resting membrane potential (RMP, Ϫ81 Ϯ 1 mV, n ϭ 33) and no spontaneous activity. Another group of myocytes was characterized by the presence of recurring DDs in which the slope of DD was 1.7 Ϯ 0.2 mV/s (n ϭ 24) but with no spontaneous APs (in the absence of drugs) and a maximum diastolic potential (MDP) of Ϫ81 Ϯ 1 mV. A small fraction of myocytes showed stable, rhythmic AP firing at a rate of 3.5 Ϯ 0.5 Hz (n ϭ 13).
In these cells, the MDP was Ϫ60 Ϯ 1 mV and a DD preceded each AP; the slope of the DD was 63 Ϯ 12 mV/s. Cells in which spontaneous activity was transient or unstable were not studied further (n ϭ 6). There were no apparent differences in the cell size or the shape of myocytes in these groups.
Late I Na enhancers ATX-II and H 2 O 2 induced DD and spontaneous firing. To determine whether an increase of late I Na can provoke an increase of spontaneous activity of atrial myocytes, ATX-II, a specific late I Na enhancer, was applied to cells that had small DD (1.8 Ϯ 0.3 mV/s, n ϭ 12) but no spontaneous AP firing. These cells had an average MDP of Ϫ81 Ϯ 1 mV (n ϭ 12). We have shown in a previous study (38) that ATX-II could induce delayed (DADs) as well as early (EADs) afterdepolarizations in atrial myocytes with a stable RMP and that the induction of DADs could be blocked by an intracellular application of the Ca 2ϩ chelator EGTA. Because DADs can lead to sustained triggered activity that may be difficult to distinguish from spontaneous AP firing due to DD, in the present study EGTA (1 mmol/l) was added to the pipette solution to prevent DADs. In 6 of 12 cells tested, ATX-II (10 nmol/l) accelerated the DD and induced rapid AP firing (Fig. 1A) . On average, the slope of DD was significantly increased by ATX-II from 1.7 Ϯ 0.6 to 10.1 Ϯ 2.7 mV/s (n ϭ 6, P Ͻ 0.05). As shown in Fig. 1A , EADs could still be induced by ATX-II, but the induction of EADs (Fig. 1A ,c) was preceded by spontaneous APs (Fig. 1A,b) . The effect of ATX-II on DD was reversed after the drug was washed out (Fig. 1A,e) . The slope of DD after washing out ATX-II was 1.9 Ϯ 0.5 mV/s, which was not significantly different from the pretreatment value (P Ͼ 0.05). In the other six cells, ATX-II induced EADs but did not accelerate the DD (not shown). No DAD was observed in this series of experiments.
ATX-II (10 nmol/l) was also applied to a cell that showed spontaneous AP firing in the absence of drugs. In this experiment (Fig. 1B) , ATX-II increased the frequency of firing from 1 to 4 Hz and the effect of ATX-II was attenuated by ranolazine (10 mol/l).
In a previous study of ventricular myocytes, we found that H 2 O 2 increased late I Na and induced EADs and that the effect of H 2 O 2 was attenuated by TTX and ranolazine (39) . Therefore, we determined whether H 2 O 2 could cause DD and spontaneous AP firing in atrial myocytes in this study.
H 2 O 2 (50 mol/l) caused spontaneous activity in all cells tested. H 2 O 2 induced DD (1.4 Ϯ 0.3 mV/s, n ϭ 9, P Ͻ 0.05) in cells with a stable RMP ( Fig. 2A) and accelerated the DD from 1.5 Ϯ 0.2 to 3.7 Ϯ 0.5 mV/s (n ϭ 12, P Ͻ 0.05) in cells with preexisting spontaneous DD (Fig. 2B) . On average, H 2 O 2 increased the slope of DD from 0.8 Ϯ 0.2 to 2.7 Ϯ 0.4 mV/s (n ϭ 21, P Ͻ 0.05). In the continuous presence of H 2 O 2 (1-3 min after DD acceleration), a rapid AP firing occurred (Fig. 2,  A and B) . The effect of H 2 O 2 to accelerate DD in atrial myocytes appeared more quickly (Ͻ2 min) in the present study than the effect to induce EADs in ventricular myocytes (Ͼ4 min) in our previous study (39) . Neither EADs nor DADs were observed in this series of experiments.
In addition to increasing late I Na , H 2 O 2 may have effects on other ion channels. Therefore, in some experiments TTX (1 mol/l, n ϭ 3) or ranolazine (5 mol/l, n ϭ 10) was applied in the presence of H 2 O 2 to selectively inhibit late I Na . As shown in Fig. 2, both TTX (Fig. 2C) and ranolazine (Fig. 2D) effectively terminated H 2 O 2 -induced rapid AP firing in all cells tested (n ϭ 13), suggesting that late I Na indeed played an important role in H 2 O 2 -induced AP firing.
Ranolazine and TTX suppressed DD and firing. In the above experiments, DD and spontaneous AP firings were induced by ATX-II and H 2 O 2 . In the absence of drugs, spontaneous DD and AP firing of atrial myocytes were also observed in this study. If late I Na plays an important role in the spontaneous activity of atrial myocytes, blocking late I Na with ranolazine or TTX should suppress spontaneous activity. This hypothesis was examined using atrial myocytes that displayed DD and stable spontaneous AP firing in the absence of drugs, i.e., cells with "intrinsic" spontaneous activity. These cells (n ϭ 13) were relatively depolarized, with an average MDP of Ϫ60 Ϯ 1 mV and an AP takeoff potential near Ϫ50 mV. The spontaneous AP firing in the absence of drugs and electrical stimulation continued at least 10 min. Neither EADs nor DADs were observed, indicating that the spontaneous firing was not a form of sustained triggered activity originating from afterdepolarizations. To determine 1) whether regular atrial APs could be induced by electrical stimulation of cells after termination of the spontaneous activity and 2) whether ranolazine at the concentrations used in this study would decrease the slope of DD and prevent the induction of atrial APs, electrical stimulation at a slow frequency of 0.16 Hz was applied to most cells.
Ranolazine at 1 mol/l (n ϭ 8, Fig. 3 , A and C) decreased the slope of DD from 61 Ϯ 15 to 11 Ϯ 5 mV/s (P Ͻ 0.05) and the frequency of spontaneous AP firing from 3.5 Ϯ 0.4 to 0.8 Ϯ 0.3 Hz (P Ͻ 0.05) and also increased the MDP from 60 Ϯ 1 to 65 Ϯ 1 mV (P Ͻ 0.05). Ranolazine at 10 mol/l completely suppressed spontaneous firing in three out of four cells tested (Fig. 3B) . The effects of ranolazine reached equilibrium within 1 min after the onset exposure of cells to the drug. When spontaneous activity was suppressed in the presence of ranolazine, APs could be induced by electrical stimulation (Fig. 3,  A,b and B,b, first AP) . The inhibitory effect of ranolazine on spontaneous activity was reversible after the drug was washed out. The slope of DD, the frequency of spontaneous AP firing, and the MDP after the washout of ranolazine were 52 Ϯ 15 mV/s (P Ͻ 0.05 vs. ranolazine treatment), 3.0 Ϯ 0.3 Hz (P Ͻ 0.05 vs. ranolazine treatment), and Ϫ60 Ϯ 1 mV (P Ͻ 0.05 vs. ranolazine treatment), respectively. These values were not significantly different (P Ͼ 0.05) from the pretreatment values of 61 Ϯ 15 mV, 3.5 Ϯ 0.4 Hz, and Ϫ60 Ϯ 1 mV for the same parameters (Fig. 3C) .
In cells with a stable RMP and no spontaneous activity, ranolazine had no significant effect on the RMP. Values of RMP in the absence and presence of 1 and 10 mol/l ranolazine were Ϫ82 Ϯ 1 (n ϭ 22), Ϫ82 Ϯ 1 (n ϭ 21), and Ϫ82 Ϯ 1 mV (n ϭ 18), respectively.
We also compared the effects of ranolazine (1 mol/l) on the amplitude (APA) and the MRS of APs of both quiescent (in the absence of electrical stimulation) and spontaneously active atrial myocytes. Myocytes were electrically stimulated at a frequency of 0.16 Hz during the experiments. In six cells without spontaneous activity, ranolazine caused a small reduction of the MRS from 124 Ϯ 6 to 115 Ϯ 8 V/s (P Ͻ 0.05) and had no significant effect on the APA (128 Ϯ 2 mV vs. control, 127 Ϯ 1 mV, P Ͼ 0.05). In five cells with spontaneous activity, the APA and MRS in the absence of drug were 82 Ϯ 2 mV and 54 Ϯ 6 V/s, respectively. In the presence of ranolazine, the spontaneous activity was suppressed and the values of APA and MRS were increased to 105 Ϯ 2 mV and 111 Ϯ 15 V/s, respectively (both, P Ͻ 0.05 vs. control).
The effect of TTX was similar to that of ranolazine. TTX (1 mol/l, n ϭ 5; Fig. 4 ) reduced the slope of DD from 65 Ϯ 22 to 21 Ϯ 17 mV/s (P Ͻ 0.05) and the frequency of spontaneous AP firing from 3.4 Ϯ 0.7 to 1.4 Ϯ 0.8 Hz (P Ͻ 0.05). The inhibitory effect of TTX on spontaneous activity was reversible. The slope of DD and the frequency of spontaneous firing after washout of TTX were 51 Ϯ 23 mV/s (P Ͻ 0.05 vs. TTX treatment; P Ͼ 0.05 vs. pretreatment) and 2.6 Ϯ 0.6 Hz (P Ͻ 0.05 vs. TTX treatment; P Ͼ 0.05 vs. pretreatment), respectively. These results thus suggested that late I Na might play an important role in the generation of spontaneous activity in atrial myocytes.
Modulation by TTX, ATX-II, H 2 O 2 , and ranolazine of inward I Na. To determine whether I Na could be activated during DD, ramp voltage-clamp pulses from Ϫ80 to Ϫ40 mV to simulate DD were applied to myocytes. In most experiments, the slope of the ramp pulse was adjusted to 66 mV/s, which was close to the slope of DD (63 Ϯ 12 mV/s) observed in spontaneously firing myocytes. During the depolarizing ramp pulse, an inward shift of membrane current starting at Ϫ70 mV was observed. The amplitude of the inward current peaked at around Ϫ50 mV and then gradually decreased (Fig. 5A) . The result suggests that an inward current with slow inactivation may be activated during DD. The peak amplitude of inward current elicited by a voltage ramp with a slope of 66 mV/s was Ϫ2.83 Ϯ 0.21 pA/pF (n ϭ 43). The amplitude of inward current was concentration-dependently reduced by 1, 3, and 10 mol/l TTX by 41 Ϯ 4 (n ϭ 10, P Ͻ 0.05), 73 Ϯ 2 (n ϭ 5, P Ͻ 0.05), and 91 Ϯ 1% (n ϭ 10, P Ͻ 0.05), respectively, suggesting that it was an Na ϩ current (Fig. 5A) . Thus the results of voltageclamp experiments were consistent with the results of currentclamp experiments and suggest that a slowly inactivating I Na , i.e., late I Na , could be activated by an applied DD.
The late I Na was also activated by square voltage-clamp pulses at membrane potentials within which DD was observed. In these experiments, membrane currents were elicited by 300-ms pulses from Ϫ90 to Ϫ50 or Ϫ60 mV in the absence and presence of TTX (3 mol/l). Late I Na was defined as TTX-inhibited current during the last 50 ms of a depolarizing pulse. A persistent, TTX-inhibited inward current was activated at both Ϫ50 and Ϫ60 mV. The average amplitude of the TTX-inhibited current during the last 50 ms of a depolarizing pulse was Ϫ0.37 Ϯ 0.04 pA/pF at Ϫ50 mV (n ϭ 14) and Ϫ0.35 Ϯ 0.06 pA/pF at Ϫ60 mV (n ϭ 3), respectively.
A Na ϩ window current might also be present during DD. The Na ϩ window current in atrial myocytes is observed within a narrow voltage range around Ϫ70 mV (34) , and the amplitude of window current is not expected to decrease with time. In contrast, the amplitude of late I Na becomes reduced as a Fig. 5B ), confirming that the slope-dependent inward current was a Na ϩ current. The ramp pulse-generated inward current was increased by the late I Na enhancers ATX-II (Fig. 6A ) and H 2 O 2 (Fig. 6B) . ATX-II (5 nmol/l, Fig. 6A ) increased the maximal amplitude of inward current by 136 Ϯ 16%, from Ϫ2.97 Ϯ 0.35 to Ϫ6.85 Ϯ 0.88 pA/pF (n ϭ 14, P Ͻ 0.05). The current showed a continuous inward shift even at the end of ramp pulse, consistent with the known effect of ATX-II to the slow inactivation of I Na (15) . Ranolazine (10 mol/l) attenuated the ATX-IIstimulated inward current by 56 Ϯ 7%. The amplitude of the inward current in the presence of both ATX-II and ranolazine was Ϫ4.99 Ϯ 0.82 pA/pF (n ϭ 14, P Ͻ 0.05 vs. ATX-II alone). The effect of ranolazine was reversible. The amplitude of the inward current measured after the washout of ranolazine in the continuous presence of ATX-II was Ϫ6.77 Ϯ 1.06 pA/pF, which was not significantly different from the value obtained before the ranolazine treatment (P Ͼ 0.05 vs. Ϫ6.85 Ϯ 0.88 pA/pF, Fig. 6A ). In three of the experiments, after the washout of ranolazine, cells were further superfused with drug-free bath solution to wash out ATX-II. The average amplitude of the inward current after the washout of ATX-II (Ϫ1.84 Ϯ 0.13 pA/pF) was not significantly different from the control (predrug) amplitude (Ϫ1.80 Ϯ 0.09 pA/pF), indicating that the effect of ATX-II was reversible.
H 2 O 2 (50 mol/l, Fig. 6B ) increased the amplitude of ramp pulse-generated inward current from Ϫ2.22 Ϯ 0.37 to Ϫ3.85 Ϯ 0.37 pA/pF (n ϭ 9, P Ͻ 0.05). The H 2 O 2 -induced inward current was completely blocked by 1 mol/l TTX, indicating that it was a Na ϩ current. The effect of TTX was reversed after washout. The amplitude of inward current after washing out TTX in the presence of H 2 O 2 was Ϫ4.43 Ϯ 0.63 pA/pF, which was not significantly different from the value measured before the TTX treatment (P Ͼ 0.05, Fig. 6B ).
DISCUSSION
Although an increased automaticity because of DD and spontaneous AP firing is frequently observed in atrial preparations of various species including humans (7, 28, 42) and has been proposed as one of the major mechanisms responsible for atrial tachyarrhythmias (29, 41) , the ionic mechanisms underlying atrial DD are unclear. The results of the present study provide evidence that late (persistent) I Na is a potential cause of DD and spontaneous AP firing of atrial myocytes.
This study was designed to test the hypothesis that late I Na contributes to the DD (spontaneous or induced by interventions) of atrial myocytes. To test the hypothesis, two enhancers (ATX-II and H 2 O 2 ) and two inhibitors (TTX and ranolazine) of late I Na were used. As expected, the two enhancers of late I Na increased the slope of DD and the frequency of AP firing in atrial myocytes (Figs. 1 and 2) . Conversely, both TTX and ranolazine reversed the effects of ATX-II and H 2 O 2 to induce automaticity ( Figs. 1 and 2) , and both compounds decreased spontaneous DD and AP firing in the absence of other interventions (Figs. 3 and 4) . Furthermore, a ramp pulse simulating DD revealed a slow inward current that was decreased by TTX In the presence of Ran (1 or 10 mol/l, A,b  and B,b, as indicated) , the spontaneous firing of action potentials was reduced or eliminated, the maximal diastolic potential (MDP) increased, and a paced action potential appeared. The spontaneous activity resumed after washout of Ran (A,c and B,c) . C: summary of actions of 1 mol/l Ran to reduce DD and spontaneous firing and to increase MDP. *P Ͻ 0.05 vs. control. and ranolazine (Figs. 5 and 6 ) and increased by ATX-II and H 2 O 2 (Fig. 6) . The amplitude of the slow inward current was dependent on the slope of the depolarizing ramp pulse (Fig.  5B) . Thus the results provide strong support for the hypothesis that late I Na contributes to the development of DD and spontaneous AP firing of atrial myocytes.
The late I Na of atrial myocytes reported here is similar to a slowly inactivating, TTX-sensitive Na ϩ current found in rabbit (2) and toad (17) pacemaker cells and in canine Purkinje cells (30) . The Na ϩ current in those cells (2, 17, 30) was also activated at negative membrane potentials and appeared to play an important role in generating DD and spontaneous AP firing.
An "equilibrium" Na ϩ window current may be generated at membrane potentials wherein Na ϩ channel activation is possible and inactivation is incomplete. The steady-state Na ϩ window current is expected to be time independent, and in atrial myocytes it is found within a small voltage range around Ϫ70 mV (34) . In this study, as shown in Fig. 5B , the amplitude of late I Na was clearly dependent on the slope of a ramp pulse, and the current was activated within a range of voltages both more positive and broader than that for window current. Thus the inward Na ϩ current elicited by ramp pulses in this study was more likely to be late I Na than Na ϩ window current. Multiple ionic mechanisms have been proposed as a cause of DD. The results of this study cannot be used to dismiss the potential contributions of ion currents other than late I Na in the generation of DD, especially at potentials wherein late I Na is expected to be very small, such as at the more negative potentials that are associated with the onset of the DD. Furthermore, although late I Na was readily induced by ramp pulses, spontaneous DD in the absence of late I Na enhancers was only observed in about 30% of tested atrial myocytes. Thus it is possible that some other membrane currents, such as those activated at more negative potentials [I f , I Ca(T) , I Na-Ca , etc.], may be responsible for initiating DD, whereas late I Na , which peaked at a membrane potential of Ϫ50 mV in our ramp pulse protocol, may contribute predominantly to the late phase of the atrial DD. Nevertheless, late I Na appears to play a critical role in the genesis of DD in atrial myocytes, because blocking this current significantly reduced the occurrence of spontaneous APs in these cells. An increase in late I Na may result in various abnormalities including EADs and DADs, depending on the tissue/cell type and cell electrical stability. ATX-II induces EADs in ventricular myocytes (40) but causes DADs as well as EADs in quiescent atrial myocytes (38) . In this study, ATX-II induced rapid AP firing in atrial myocytes that had spontaneous DD (Fig. 1) . ATX-II did not induce spontaneous APs in cells with a stable RMP (38) . A possible explanation for this observation is that ATX-II may have increased the outward component of the inward rectifier K ϩ current (I K1 ) (15) that might partially counter the effect of inward late I Na . This explanation is consistent with the observation that ATX-II can induce DADs in ventricular myocytes when I K1 is reduced (38) . H 2 O 2 induces EADs in ventricular myocytes (39) , whereas it induced DD and spontaneous firing in all atrial myocytes tested in the present study. These results are not contradictory. Ventricular myocytes are known to have a higher density of I K1 (10, 46) and thus a more stable RMP compared with atrial cells. The difference of response to an enhancement of late I Na suggests that other currents modulate the response to I Na and that the magnitude of these other ion currents depends on cell type.
The fraction of atrial myocytes that showed various degrees of spontaneous DD in our experiments was ϳ30%. This percentage is similar to that reported in a study in which 29% of myocytes isolated from cat right atrium had spontaneous DD (50) . The reason why some atrial myocytes did but others did not exhibit intrinsic spontaneous DD in both of these studies is unclear. A simple speculation would be that spontaneous activity is the result of membrane damage that occurred during cell isolation. However, this explanation is not supported by the facts that 1) spontaneous activity has been observed not only in isolated single atrial myocytes (14, 50) but also in intact atrial preparations (7, 13, 28, 31, 32, 42, 49) ; 2) DD and spontaneous firing could be induced and accelerated by late I Na enhancers in cells with a stable RMP or small DD (Figs. 1 and 2); and 3) when spontaneous AP firing was terminated by ranolazine, regular atrial APs could be induced, and the drug actions were reversible (Fig. 3) . Atrial tissues are known for possessing complex structure and regional electrophysiological heterogeneity (9, 20) . Atrial myocytes in certain areas of the atrium (e.g., the Eustachian ridge) tend to develop spontaneous DD (13, 31) and to be a source of ectopic activity (21, 27) . Although it remains to be confirmed, it is plausible to speculate that the density of late I Na and/or other ion currents critical to the development of DD (e.g., I K1 ) may vary among atrial myocytes, resulting in individual variation of membrane electrical stability.
Ranolazine at 1 and 10 mol/l effectively attenuated spontaneous DD and AP firing but had little effect on pacinginduced APs (Fig. 3) . The ionic mechanism underlying the apparent selective effect of ranolazine to reduce DD but not pacing-induced APs is unclear. However, ranolazine is reported to reduce peak I Na and AP upstroke velocity only at relatively high concentrations (1, 43) . Therefore, the present results suggest that ranolazine at a low concentration may preferentially inhibit late versus peak I Na , as reported by a study of ventricular myocytes (43) . Whether ranolazine also preferentially inhibits late I Na in atrial myocytes remains to be determined. The effects of 1 and 10 mol/l ranolazine to reduce spontaneous DD and AP firing are not likely due to the inhibition of an inward Ca 2ϩ current. The IC 50 value for ranolazine to reduce I Ca in canine atrial myocytes was reported to be 311 mol/l (36). Furthermore, in this study the specific I Na inhibitor TTX had effects that were similar to those of ranolazine.
Implications. The results of the present study show that H 2 O 2 , a reactive oxygen species that is formed during cardiac Fig. 6 . Ramp pulse-generated slow inward current was enhanced by ATX-II and H2O2 and attenuated by Ran and TTX. A, top: superimposed currents recorded from a single cell in the absence of drug (control) and in the presence of 5 nmol/l ATX-II or ATX-II plus 10 mol/l Ran. A, bottom: summary of results of experiments to measure the amplitude of inward current in the absence of drug (control), in the presence of ATX-II or ATX-II plus Ran, and after washout of Ran in the presence of ATX-II (ATX-IIЈ). *P Ͻ 0.05 and **P Ͻ 0.05 vs. control and ATX-II alone, respectively. B, top: superimposed currents recorded from a single cell in the absence of drug (control) and in the presence of 50 mol/l H2O2 or H2O2 plus 1 mol/l TTX. Note that the basal inward current in this cell was partially inhibited by TTX. B, bottom: summary of the amplitude of inward current measured in the absence of drug (control), in the presence of H2O2 or H2O2 plus TTX, and after washout of TTX in the presence of H2O2 (H2O2Ј). *P Ͻ 0.05 and **P Ͻ 0.05 vs. control and H2O2 alone, respectively. ischemia-reperfusion (37), induced DD and AP firing in atrial myocytes. In addition to H 2 O 2 , a number of pathogenic factors may enhance late I Na and have the potential to induce atrial DD. For example, the amplitude of late I Na was reportedly increased in heart failure (25, 44) and by glycolytic pathway metabolites (18) , hypoxia (11, 45) , inflammation (47) , and hyperthyroxinemia (12) . Because late I Na can be activated at relatively negative membrane potentials (5, 33, 35) , this current may play a significant role in the development of arrhythmic activity under pathological conditions wherein it is enhanced. Moreover, an enhanced late I Na due to SCN5A gainof-function mutations underlies type 3 long-QT syndrome (LQT3), and multiple studies have reported an increased incidence of atrial fibrillation in patients with LQT3 (3, 6, 16, 51) .
In conclusion, the results of the present study suggest that late I Na contributes to DD that may lead to spontaneous APs of atrial myocytes. A selective inhibition of late I Na to suppress atrial spontaneous activity may prove to be a potential antiarrhythmic strategy. Future studies are needed to elucidate the potential role of late I Na to enhance atrial automaticity in diseased atria and, hence, in atrial tachyarrhythmias, including atrial automatic tachycardia.
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